SCHEMBL1660385

SCHEMBL1660385

CCOc1cccc(C2(O)CCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.46
TP53 P04637 2/20 0.46
CYP3A4 P08684 1/20 0.46
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
OPRL1 P41146 1/20 0.44
ALDH1A1 P00352 4/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
NPY1R P25929 3/20 0.43
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 2/20 0.40
HTT P42858 1/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16566321 0.83 GRIN1 (0.62) KMT2AOPRM1OPRD1OPRK1OPRL1
SCHEMBL1660644 0.81 OPRM1 (0.61) KMT2AOPRM1OPRD1OPRK1OPRL1
SCHEMBL13959718 0.81 TAAR1 (0.44) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL6584414 0.80 CYP4F2 (0.51) CYP4F2CYP4A11
SCHEMBL20789956 0.80 HRH3 (0.55) KMT2AALDH1A1TSHRHPGDKDM4E
SCHEMBL13959465 0.78 TAAR1 (0.44) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL6831189 0.78 OPRM1 (0.61) KMT2AOPRM1OPRD1OPRK1OPRL1
Hydrochloric Acid SCHEMBL8611782 0.78 KMT2A (0.42) KMT2ATP53CYP3A4OPRM1OPRD1
Hydrochloric Acid SCHEMBL9057167 0.78 POLB (0.65) KMT2AOPRM1OPRD1OPRK1OPRL1
SCHEMBL19291541 0.77 TP53 (0.46) KMT2ATP53CYP3A4ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed